Gideon Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-7,314
| Closed | -$1.24M | – | 393 |
|
|
2019
Q3 | $1.24M | Buy |
+7,314
| New | +$1.24M | 0.41% | 92 |
|
|
2019
Q2 | – | Sell |
-2,529
| Closed | -$465K | – | 443 |
|
|
2019
Q1 | $465K | Sell |
2,529
-12
| -0.5% | -$2.21K | 0.17% | 185 |
|
|
2018
Q4 | $421K | Buy |
+2,541
| New | +$421K | 0.17% | 185 |
|
|
2018
Q3 | – | Sell |
-2,070
| Closed | -$352K | – | 503 |
|
|
2018
Q2 | $352K | Sell |
2,070
-1,216
| -37% | -$207K | 0.18% | 221 |
|
|
2018
Q1 | $536K | Buy |
+3,286
| New | +$536K | 0.33% | 106 |
|
|
2017
Q3 | – | Sell |
-1,755
| Closed | -$226K | – | 383 |
|
|
2017
Q2 | $226K | Buy |
+1,755
| New | +$226K | 0.25% | 202 |
|
|
2015
Q3 | – | Sell |
-3,440
| Closed | -$425K | – | 333 |
|
|
2015
Q2 | $425K | Buy |
+3,440
| New | +$425K | 0.18% | 156 |
|